BioSpace News Archive

A protocol involving tumor removal and immediate jaw reconstruction – replacing jawbone with viable bone from the patient’s own leg – can effectively treat lower-jaw tumors with few complications in children, according to a new study.

Gartner, Inc., the world’s leading research and advisory company, reported results for the fourth quarter 2020 and provided its financial outlook for the full year 2021.

Transitional Pass Through Payment (TPT) Facilitates Patient Access to New and Innovative Products That Have Shown Substantial Clinical Improvement

Trefoil Therapeutics today announced it has begun a Phase 2 clinical trial of its engineered Fibroblast Growth Factor-1, TTHX1114, to evaluate its safety and efficacy as a regenerative treatment for patients with Fuchs Endothelial Corneal Dystrophy (FECD)

908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, announced the appointment of industry veteran Steve Davenport as Vice President of Commercial Sales.

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that 11 new partner programs entered clinical development in 2020.

MediXall Group, Inc., a healthcare technology company, announced it has launched Health Karma for Employers, a health services platform that provides millions of businesses with the ability to offer affordable, high-quality healthcare benefits to their employees, whether they are eligible for health insurance coverage or not.

Nationally-Recognized Research and the Imperative for Health Systems to Free Beds and Improve Outcomes More Quickly Fuel Insulin Dosing Technology Company’s Growth

ZebiAI, Inc., a biotech company focused on improving human health by powering machine learning (ML) to source novel targets and discover new therapeutics, today announced the appointment of Brian Goldman, Ph.D., as SVP and Chief Computation Officer.

PatientsLikeMe, the world’s largest integrated community, health management, and real-world data platform, today announced it has raised $26 million in financing led by Alta Partners, Hambrecht Ducera Growth Ventures, Optum Ventures and PBM Capital, with participation from Jeff Leerink and Symphony Ventures, an investment partnership established by Rory McIlroy and his team.